NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV (NAMS) Option Chain
As of September 25, 2026, NewAmsterdam Pharma Company NV is trading at $22.66, a +0.36% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 57.7%. IV Rank is 5%.
Read more
Tracking the NAMS option chain helps you see every strike and expiry on NewAmsterdam Pharma Company NV in one view, so you can quickly identify the contracts that fit your thesis and your risk. NewAmsterdam Pharma Company NV's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of NAMS options activity at a glance. Use our scanner to monitor the NAMS option chain in real time and filter for the NAMS options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For NAMS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the NAMS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where NAMS stock options are being actively traded and where they are not.
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein cholesterol (HDL-C). The company was founded in 2019 and is based in Naarden, the Netherlands.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls NewAmsterdam Pharma Company NV's full chain across every expiry, highlights the most liquid strikes, and lets you screen NAMS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of NAMS stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile9.52% Subdued
- Market cap (M$)2,699
- 52 weeks high-46.49%
- 52 weeks low7.42%
- Analyst recommendationStrong Buy
1.12 - Target price$51.80
128.60% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E—
- Future P/E—
- EPS (ttm)-2.18
- EPS growth next 5 years37.44%
As of September 25, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 3.58 | 1 | 0 | 0.29 | 5.16 | 3.70 | 7.20 | 17.50 | -22.50 | — | 2.20 | 0.00 | 2.20 | 0 | 0 | 96.42 |
| 20.32 | 1 | 0 | 0.67 | 2.66 | 1.55 | 5.10 | 20.00 | -11.43 | — | 0.80 | 0.00 | 0.80 | 1 | 2 | 79.68 |
| 51.04 | 577 | 0 | 1.46 | 0.16 | 0.05 | 3.20 | 22.50 | -0.35 | — | 2.75 | 0.00 | 2.75 | 0 | 79 | 48.96 |
| 78.59 | 384 | 3 | 0.40 | 0.00 | 0.25 | 0.55 | 25.00 | +10.72 | 2.50 | 2.95 | 2.34 | 0.39 | 0 | 193 | 21.41 |
| 98.29 | 544 | 0 | 0.25 | 0.00 | — | 0.25 | 30.00 | +32.86 | 5.80 | 9.10 | 7.34 | 0.11 | 0 | 0 | 1.71 |
As of September 25, 2026
Scan the full option chain in one place
Browse the full NAMS option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→